Peg IFNα-2b Therapy for Unresectable Mid to Late Stage HBV-HCC
Clinical trial NCT07769827 · RECRUITING
Trial details
- NCT number
- NCT07769827
- Sponsor
- Jinling Hospital, China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-26
- Primary completion
- 2028-03-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.